Baker Bros. Advisors LP 13D and 13G filings for Kala Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-31 4:18 pm Purchase |
2024-12-29 | 13D | Kala Pharmaceuticals, Inc. KALA |
Baker Bros. Advisors LP | 1,201,894 19.700% |
310,559 (+34.84%) |
Filing |
| 2024-06-28 4:11 pm Purchase |
2024-06-26 | 13D | Kala Pharmaceuticals, Inc. KALA |
Baker Bros. Advisors LP | 891,335 19.990% |
622,122 (+231.09%) |
Filing |
| 2024-02-14 4:21 pm Purchase |
2023-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA |
Baker Bros. Advisors LP | 269,213 9.990% |
88,300 (+48.81%) |
Filing |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA |
Baker Bros. Advisors LP | 180,913 9.990% |
180,913 (New Position) |
Filing |